Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2021 - Volume 25, Number 6
View All Articles in Issue
Page(s): 509
Download in electronic PDF format for $75
Abstract: A formulation for preparing Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, ziprasidone mesylate, oral suspension, formulation, sedative, tic disorder, children
Related Categories: FORMULATIONS, PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY